The city of Spokane Valley, Washington, currently has 1 active clinical trials seeking participants for Alzheimer's Disease research studies.
A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)
Recruiting
The main purpose of this study is to evaluate the safety and efficacy of donanemab in participants with preclinical Alzheimer's Disease (AD). Approximately 800 additional participants will be enrolled in a 12-month addendum to assess safety of a different titration regimen.
Gender:
ALL
Ages:
Between 65 years and 80 years
Trial Updated:
02/18/2025
Locations: Coram CVS/Specialty Infusion Services - Spokane Valley, Spokane Valley, Washington
Conditions: Alzheimer Disease